Request Deal Involvement

Vida Ventures and Leaps by Bayer led a $175m funding round in Affini-T Therapeutics.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Cooley

legal advisors

Cooley

Cooley

legal advisors

Cooley

Canale Communications

pr advisors

Canale Communications

or

Principals

ERASCA VENTURES

bidder

ERASCA VENTURES

FRED HUTCHINSON CANCER RESEARCH CENTER

bidder

FRED HUTCHINSON CANCER RESEARCH CENTER

HUMBOLDT FUND

bidder

HUMBOLDT FUND

PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY

bidder

PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY

CATALIO CAPITAL MANAGEMENT

bidder

CATALIO CAPITAL MANAGEMENT

AGENT CAPITAL

bidder

AGENT CAPITAL

ALEXANDRIA VENTURE INVESTMENTS

bidder

ALEXANDRIA VENTURE INVESTMENTS

VIDA VENTURES

bidder

VIDA VENTURES

AFFINI-T THERAPEUTICS

target

AFFINI-T THERAPEUTICS

LEAPS BY BAYER

bidder

LEAPS BY BAYER

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite